Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.
about
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationUtility of noninvasive biomatrices in pharmacokinetic studies.Anticonvulsants and breast feeding: a critical review.A novel index for expressing exposure of the infant to drugs in breast milk.An in vitro technique for the rapid determination of drug entry into breast milkSSRIs during breastfeeding: spotlight on milk-to-plasma ratio.Excretion of antihypertensive medication into human breast milk: a systematic review.Prediction of milk/plasma concentration ratio of drugs.Antidepressant Use During Breastfeeding.Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.Distribution and excretion of sertraline and N-desmethylsertraline in human milk.Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infantsDistribution and excretion of fluoxetine and norfluoxetine in human milk.Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.Drug use and breastfeeding.Individualized drug and dose: the clinical pharmacologist's calling or curse?Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosisTherapy insight: the use of antirheumatic drugs during nursing.Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs.Cultured mammary epithelial monolayers (BME-UV) express functional organic anion and cation transporters.Prediction of drug disposition on the basis of its chemical structure.Modeling drug passage into human milk.Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport.Cimetidine does not appear to influence the distribution of metformin into human milk.Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants.Prediction of milk/plasma drug concentration (M/P) ratio using support vector machine (SVM) method.Estimation of Riluzole Levels in Human Milk and Infant Exposure During Its Use in a Patient With ALS.Contribution of protein binding, lipid partitioning, and asymmetrical transport to drug transfer into milk in mouse versus human.Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant.Transfer of Low Dose Aspirin Into Human Milk.
P2860
Q26765038-F7FA59DF-7B00-497C-918B-6FEFC96C3C4FQ31126290-37F80ED7-62AF-4DB0-A014-76E1B4B227B2Q33999176-56ACF25E-12B0-4136-ADF5-C8B0C91C9208Q34346533-A388550D-A4C8-4512-BB19-7A6B483AFDC9Q34347542-0AA28B54-1A6D-4ED3-B79C-88F7542DAC8EQ34575271-ED9F09EE-E73E-4E2B-910F-50C054D4733DQ34666718-C33CC589-90AD-49C9-976E-FD95E22F07D4Q35201053-D48D64E8-58DB-4FB4-A43C-25EE8BC2261DQ35701332-ADF72BD0-4CF1-45E4-B7AA-3F12B3254F47Q35802378-4F2B1A33-4B5E-4DA4-BF89-529EB914CA0AQ35802384-08755144-FF3A-4602-958A-2217EEE08AB8Q35804367-3588588C-75BB-4721-9520-31A367AE1F80Q36053901-FC021680-7071-4917-8318-80621AD1E629Q36055255-C0806ADB-7C84-4312-8959-A711C50AB1FBQ36191050-2666A6F4-EE88-4DF0-A54E-4A57651E54F6Q36365374-74C9C347-F9C7-4910-91A0-5FE228C03913Q36535979-A48F8008-7ACE-4531-AD8B-02A4FE45BCB0Q36864030-FA7F7F96-60DD-4A73-A271-3BE3983E87B4Q37133280-C1F70DA6-BC38-446E-AC31-161318DB0702Q37353975-EA99E0A8-D155-4A11-9DD0-E8F954957C80Q38086778-4486C4DC-F02F-426B-822C-3729B29FE502Q38802791-905A1370-75B0-4C13-A874-DA8202E41783Q39039141-2B7BE5D8-9CCC-4AE7-8308-B02D9D35BF14Q41413212-1BD5BB67-F791-4F26-875E-7774BDEC578FQ42706823-CB175FCA-5875-4C83-8CFD-AD46183A2B03Q42758650-72676434-C80B-43CC-9354-1828ACE05F89Q44007922-8EBA3BB6-E391-4F34-9252-77CF3E5757D4Q47360087-7BD78C70-5120-4B8C-AD9F-E57F01742EB7Q50180959-AD925962-67CE-4B61-9064-30607A36D0AAQ50949503-9BC3802C-7CFD-4DD8-8E6D-0508AD5F0372Q52017863-5F47BBE9-3EAA-4200-9029-9E2803033D59Q53626094-79986D8F-1B78-465A-B083-6F3C947EFB76
P2860
Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Prospective evaluation of a mo ...... ysicochemical characteristics.
@ast
Prospective evaluation of a mo ...... ysicochemical characteristics.
@en
Prospective evaluation of a mo ...... ysicochemical characteristics.
@nl
type
label
Prospective evaluation of a mo ...... ysicochemical characteristics.
@ast
Prospective evaluation of a mo ...... ysicochemical characteristics.
@en
Prospective evaluation of a mo ...... ysicochemical characteristics.
@nl
prefLabel
Prospective evaluation of a mo ...... ysicochemical characteristics.
@ast
Prospective evaluation of a mo ...... ysicochemical characteristics.
@en
Prospective evaluation of a mo ...... ysicochemical characteristics.
@nl
P2093
P2860
P1476
Prospective evaluation of a mo ...... ysicochemical characteristics.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1992.TB04077.X
P407
P577
1992-05-01T00:00:00Z